Hysbysiad dyfarnu contract
Canlyniadau'r weithdrefn gaffael
Adran I:
Endid
contractio
I.1) Enw a chyfeiriad
Business Energy and Industrial Strategy
1 Victoria Street
London
SW1H0ET
UK
E-bost: VTFContracts@beis.gov.uk
NUTS: UKI32
Cyfeiriad(au) rhyngrwyd
Prif gyfeiriad: https://www.gov.uk/government/organisations/department-for-business-energy-and-industrial-strategy
I.4) Y math o awdurdod contractio
Gweinyddiaeth neu unrhyw awdurdod cenedlaethol neu ffederal arall, gan gynnwys eu his-adrannau rhanbarthol neu leol
I.5) Prif weithgaredd
Gwasanaethau cyhoeddus cyffredinol
Adran II: Gwrthrych
II.1) Cwmpas y caffaeliad
II.1.1) Teitl
Advance Purchase Agreement
Cyfeirnod: 2611/09/2020
II.1.2) Prif god CPV
33651600
II.1.3) Y math o gontract
Cyflenwadau
II.1.4) Disgrifiad byr
Procurement of the Covid-19 Adjuvanted Pandemic Vaccine.
II.1.6) Gwybodaeth am lotiau
Mae’r contract hwn wedi’i rannu’n lotiau:
Na
II.1.7) Cyfanswm gwerth y caffaeliad
Gwerth heb gynnwys TAW: 1.00 GBP
II.2) Disgrifiad
II.2.3) Man cyflawni
Cod NUTS:
UK
II.2.4) Disgrifiad o’r caffaeliad
Procurement of the Covid-19 Adjuvanted Pandemic Vaccine.
II.2.5) Meini prawf dyfarnu
Price
II.2.11) Gwybodaeth am opsiynau
Opsiynau:
Na
II.2.13) Gwybodaeth am Gronfeydd yr Undeb Ewropeaidd
Mae'r broses gaffael yn gysylltiedig â phrosiect a/neu raglen a ariennir gan gronfeydd yr Undeb Ewropeaidd:
Na
II.2.14) Gwybodaeth ychwanegol
Contract value is being withheld due to commercial sensitivity (PCR 2015 Reg 50(6)(b) and (c) and FOIA 2000 Section 43). Publication may enable competitors to calculate cost per dose. This will commercially prejudice:
(i) the supplier in its negotiations with other national governments; and
(ii) the contracting authority in negotiations with other vaccine vendors. It may also impact fair competition between vaccine vendors.
Section IV: Gweithdrefn
IV.1) Disgrifiad
IV.1.1) Y math o weithdrefn
Dyfarnu contract heb gyhoeddi galwad am gystadleuaeth yng Nghyfnodolyn Swyddogol yr Undeb Ewropeaidd ymlaen llaw
Cyfiawnhau'r weithdrefn ddyfarnu a ddewiswyd:
Dim ond am y rheswm canlynol y gall gweithredwr economaidd penodol ddarparu'r gwaith, y cyflenwadau neu'r gwasanaethau: diffyg cystadleuaeth am resymau technegol
Esboniad
The award of the contract to Aventis Pharma and GSK is strictly necessary due to absence of competition for technical reasons. Regulation 32 (b)(ii).
Furthermore, this Advance Purchase Agreement is the execution of the previous Capacity Reservation Agreement (Please see linked notice)
IV.1.8) Gwybodaeth am Gytundeb Caffael y Llywodraeth (GPA)
The procurement is covered by the Government Procurement Agreement:
Ydy
IV.2) Gwybodaeth weinyddol
IV.2.1) Cyhoeddiad blaenorol mewn perthynas â’r weithdrefn hon
Rhif yr hysbysiad yn OJ S:
2020/S 227-560526
Section V: Dyfarnu contract
Rhif Contract: 2611/09/2020
Teitl: Advance Purchase Agreement
Dyfernir contract/lot:
Ydy
V.2 Dyfarnu contract
V.2.1) Y dyddiad y daeth y contract i ben
20/09/2021
V.2.2) Gwybodaeth am dendrau
Nifer y tendrau a ddaeth i law: 1
Dyfarnwyd y contract i gr?p o weithredwyr economaidd:
Ydy
V.2.3) Enw a chyfeiriad y contractwr
Aventis Pharma Ltd
Thames Valley Park Drive, Reading
Berkshire
RG6 1PT
UK
NUTS: UK
BBaCh yw’r contractwr:
Na
V.2.3) Enw a chyfeiriad y contractwr
GlaxoSmithKline Biologicals S.A
Rue de l'Institut 89
Rixensart
B-1330
BE
NUTS: BE
BBaCh yw’r contractwr:
Na
V.2.4) Gwybodaeth am werth y contract/lot (heb gynnwys VAT)
Amcangyfrif cychwynnol o gyfanswm gwerth y contract/lot: 1.00 GBP
Cyfanswm gwerth y contract/lot: 1.00 GBP
V.2.5) Gwybodaeth am is-gontractio
Section VI: Gwybodaeth ategol
VI.3) Gwybodaeth ychwanegol
Additional information: contract end date is being withheld on grounds that release would be contrary to public interest (Reg 50(6)(a)) and commercial sensitivity (Reg 50(6)(b) and (c)). The date is variable based on production and delivery. Given significant challenges to overcome, the end date may set unrealistic expectation for the public/market. Also, given significant competition to bring to the market a successful vaccine, provision of the contract term is valuable information to competitors that may impact negotiations/future competition.
VI.4) Gweithdrefnau adolygu
VI.4.1) Corff adolygu
Department of Business, Energy and Industrial Strategy
1 Victoria Street, Westminister
London
SW1H 0ET
UK
VI.5) Dyddiad anfon yr hysbysiad hwn
20/10/2021